Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All andrographolide studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchAndrographolideAndrographol.. (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Effects and Mechanisms of Andrographolide for COVID-19: A Network Pharmacology-Based and Experimentally Validated Study

Zhang et al., Natural Product Communications, doi:10.1177/1934578X241288428
Oct 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
In Silico and In Vitro study showing that andrographolide inhibits SARS-CoV-2 pseudovirus entry and replication and suppresses proinflammatory cytokine expression in BEAS-2B bronchial epithelial cells. Network pharmacology analysis identified key molecular targets of andrographolide implicated in COVID-19 pathogenesis, including STAT3, IL-6, TNF, and IL-1β. Molecular docking showed favorable binding of andrographolide to these targets. Authors found that andrographolide dose-dependently inhibited the mRNA expression of IL-6, TNF-α, IL-1β, and STAT3 and suppressed pseudovirus entry and replication, suggesting a dual role for COVID-19 by modulating inflammation and exhibiting antiviral activity.
22 preclinical studies support the efficacy of andrographolide for COVID-19:
Zhang et al., 7 Oct 2024, peer-reviewed, 10 authors. Contact: wentaoguo@126.com.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperAndrographol..All
Effects and Mechanisms of Andrographolide for COVID-19: A Network Pharmacology-Based and Experimentally Validated Study
Jingyi Zhang, Hongmei Lu, Yongdui Ruan, Shiyi Huang, Siying Deng, Yinuo Wang, Qing Li, Zuguo Zhao, Long Feng, Wentao Guo
Natural Product Communications, doi:10.1177/1934578x241288428
Objective: This study aimed to elucidate the therapeutic effects and underlying mechanisms of andrographolide against COVID-19 through a network pharmacology approach and experimental validation. Methods: Network pharmacology approaches were employed to elucidate potential targets of andrographolide, investigating their overlap with proteins implicated in SARS-CoV-2 infection. The identified targets underwent further analysis through protein-protein interaction (PPI) mapping, gene ontology (GO) categorization, and pathway enrichment within the framework of the Kyoto Encyclopedia of Genes and Genomes (KEGG). Subsequent molecular docking studies provided insights into the binding dynamics between andrographolide and the relevant protein targets. To validate these findings, a series of experimental procedures were conducted, including cytotoxicity assays, quantitative PCR analyses, and the deployment of a SARS-CoV-2 pseudovirus system, using BEAS-2B lung epithelial cells as a model. Results: Bioinformatics analysis revealed that andrographolide potentially modulates proinflammatory cytokines, JAK-STAT signaling, and antiviral immunity pathways in COVID-19. Molecular docking showed favorable binding interactions between andrographolide and its putative targets. In vitro studies confirmed that andrographolide suppressed the mRNA expression of IL-6, TNFα, IL-1β, and STAT3 and inhibited pseudovirus entry and infection at pharmacologically relevant concentrations. Conclusion: The findings suggest that andrographolide could be a promising candidate for the treatment of COVID-19 due to its capacity to both inhibit SARS-CoV-2 and modulate harmful inflammation. Our findings highlight the potential therapeutic value of andrographolide in treating COVID-19, warranting further exploration in clinical trials.
Authors Contributions Jingyi Zhang and Hongmei Lu participated in the experiments, collated data, visualized data, and performed statistical analysis. Hongmei Lu and Yongdui Ruan reviewed the manuscript and provided funding. Wentao Guo was responsible for research oversight. Shiyi Huang and Siying Deng provided suggestions and ideas for manuscript writing. Zuguo Zhao and Long Feng contributed to research execution, management, and coordination. Jingyi Zhang, Hongmei Lu, and Yongdui Ruan contributed equally to this work. All authors contributed to the article and approved the final manuscript version. Declaration of Conflicting Interests The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Ethical Approval Ethical approval is not applicable for this article. Statement of Informed Consent There are no human subjects in this article and informed consent is not applicable.
References
Adiguna, Panggabean, Atikana, Antiviral activities of andrographolide and its derivatives: mechanism of action and delivery system, Pharmaceuticals
Ashburner, Ball, Blake, Gene Ontology: tool for the unification of biology, Nat Genet
Berman, Westbrook, Feng, The protein data bank, Nucleic Acids Res
Bystrom, Taher, Henson, Metabolic requirements of Th17 cells and of B cells: regulation and defects in health and in inflammatory diseases, Front Immunol
Catanzaro, Fagiani, Racchi, Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2, Signal Transduct Target Ther
Chowdhury, Chowdhury, Mahmud, Drug repurposing approach against novel coronavirus disease (COVID-19) through virtual screening targeting SARS-CoV-2 main protease, Biology
Daina, Michielin, Zoete, SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules, Sci Rep, doi:10.1038/srep42717
Fiebelkow, Guendel, Guendel, The tyrosine phosphatase SHP2 increases robustness and information transfer within IL-6-induced JAK/STAT signalling, Cell Commun Signal
Gao, Peng, Shan, Inhibition of AIM2 inflammasomemediated pyroptosis by Andrographolide contributes to amelioration of radiation-induced lung inflammation and fibrosis, Cell Death Dis
George, Mayne, The novel coronavirus and inflammation, Adv Exp Med Biol, doi:10.1007/978-3-030-59261-5_11
Gfeller, Michielin, Zoete, Shaping the interaction landscape of bioactive molecules, Bioinformatics
Grosdidier, Zoete, Michielin, Swissdock, a protein-small molecule docking web service based on EADock DSS, Nucleic Acids Res
Gusev, Sarapultsev, Solomatina, SARS-CoV-2-Specific immune response and the pathogenesis of COVID-19, Int J Mol Sci
Hossain, Urbi, Karuniawati, Andrographis paniculata (Burm. f.) Wall. ex Nees: an updated review of phytochemistry, antimicrobial pharmacology, and clinical safety and efficacy, Life
Hu, Bian, Rong, JAK/STAT pathway: extracellular signals, diseases, immunity, and therapeutic regimens, Front Bioeng Biotechnol
Hu, Li, Fu, The JAK/STAT signaling pathway: from bench to clinic, Signal Transduct Target Ther
Huang, Wang, Li, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet
Huang, Zhang, Zhang, Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms, Pharmacol Ther
Kim, Chen, Cheng, Pubchem 2019 update: improved access to chemical data, Nucleic Acids Res
Li, Lu, Ruan, Andrographolide suppresses SARS-CoV-2 infection by downregulating ACE2 expression: a mechanistic study, Antiviral Ther
Li, Yu, Li, Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics, Nucleic Acids Res
Mahmud, Paul, Afroze, Efficacy of phytochemicals derived from avicennia officinalis for the management of COVID-19: a combined in silico and biochemical study, Molecules
Martonik, Parfieniuk-Kowerda, Rogalska, The role of Th17 response in COVID-19, Cells
Mehta, Mcauley, Brown, COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet
Mooers, Shortcuts for faster image creation in PyMOL, Protein Sci
Nazerian, Ghasemi, Yassaghi, Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: molecular pathways and potential therapeutic options, Int Immunopharmacol
Nie, Li, Wu, Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2, Emerging Microbes Infect
Otasek, Morris, Bouças, Cytoscape Automation: empowering workflow-based network analysis, Genome Biol
Piñero, Ramírez-Anguita, Saüch-Pitarch, The DisGeNET knowledge platform for disease genomics: 2019 update, Nucleic Acids Res
Rabaan, Sh, Garout, Diverse immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter cytokine storm and inflammatory responses, Pathogens
Ren, Xu, Sun, Current trends on repurposing and pharmacological enhancement of andrographolide, Curr Med Chem
Ru, Li, Wang, TCMSP: a database of systems pharmacology for drug discovery from herbal medicines, J Cheminform
Ruan, Yang, Wang, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med
Sa-Ngiamsuntorn, Suksatu, Pewkliang, Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its Major component andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives, J Nat Prod
Safran, Dalah, Alexander, Genecards Version 3: the human gene integrator, Database: J Biol Databases Curat
Sigaud, Albert, Hess, MAPK Inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas, Nat Commun
Szklarczyk, Gable, Lyon, STRING V11: proteinprotein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets, Nucleic Acids Res
Szklarczyk, Santos, Von Mering, Jensen, Bork et al., STITCH 5: Augmenting protein-chemical interaction networks with tissue and affinity data, Nucleic Acids Res
Tay, Poh, Rénia, The trinity of COVID-19: immunity, inflammation and intervention, Nat Rev Immunol
Trott, Olson, Autodock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading, J Comput Chem
Vetvicka, Vannucci, Biological properties of andrographolide, an active ingredient of Andrographis Paniculata: a narrative review, Ann Transl Med
Wen, Kuo, Jan, Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus, J Med Chem
Whirl-Carrillo, Mcdonagh, Hebert, Pharmacogenomics knowledge for personalized medicine, Clin Pharmacol Ther
Wishart, Feunang, Guo, Drugbank 5.0: a major update to the DrugBank database for 2018, Nucleic Acids Res
Zhu, Hou, Yang, Network pharmacology integrated with experimental validation revealed the anti-inflammatory effects of Andrographis paniculata, Sci Rep
Zhu, Zhang, Wang, A novel coronavirus from patients with pneumonia in China, N Engl J Med
{ 'indexed': {'date-parts': [[2024, 10, 8]], 'date-time': '2024-10-08T11:40:38Z', 'timestamp': 1728387638734}, 'reference-count': 46, 'publisher': 'SAGE Publications', 'issue': '10', 'license': [ { 'start': { 'date-parts': [[2024, 10, 1]], 'date-time': '2024-10-01T00:00:00Z', 'timestamp': 1727740800000}, 'content-version': 'unspecified', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc/4.0/'}], 'funder': [ { 'name': 'Guangdong Provincial Bureau of Traditional Chinese Medicine Scientific Research ' 'Project', 'award': ['20211220', '20232097']}, { 'name': 'Discipline Construction Project of Guangdong Medical University', 'award': ['4SG21229GDGFY01']}, {'name': 'Guangdong Medical University Scientific Research Project', 'award': ['GDMUQ2021005']}, {'name': 'Social Science Development Project of Dongguan City', 'award': ['20211800905542']}], 'content-domain': {'domain': ['journals.sagepub.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2024, 10]]}, 'abstract': '<jats:p> Objective: This study aimed to elucidate the therapeutic effects and underlying ' 'mechanisms of andrographolide against COVID-19 through a network pharmacology approach and ' 'experimental validation. Methods: Network pharmacology approaches were employed to elucidate ' 'potential targets of andrographolide, investigating their overlap with proteins implicated in ' 'SARS-CoV-2 infection. The identified targets underwent further analysis through ' 'protein-protein interaction (PPI) mapping, gene ontology (GO) categorization, and pathway ' 'enrichment within the framework of the Kyoto Encyclopedia of Genes and Genomes (KEGG). ' 'Subsequent molecular docking studies provided insights into the binding dynamics between ' 'andrographolide and the relevant protein targets. To validate these findings, a series of ' 'experimental procedures were conducted, including cytotoxicity assays, quantitative PCR ' 'analyses, and the deployment of a SARS-CoV-2 pseudovirus system, using BEAS-2B lung ' 'epithelial cells as a model. Results: Bioinformatics analysis revealed that andrographolide ' 'potentially modulates proinflammatory cytokines, JAK-STAT signaling, and antiviral immunity ' 'pathways in COVID-19. Molecular docking showed favorable binding interactions between ' 'andrographolide and its putative targets. In vitro studies confirmed that andrographolide ' 'suppressed the mRNA expression of IL-6, TNF-α, IL-1β, and STAT3 and inhibited pseudovirus ' 'entry and infection at pharmacologically relevant concentrations. Conclusion: The findings ' 'suggest that andrographolide could be a promising candidate for the treatment of COVID-19 due ' 'to its capacity to both inhibit SARS-CoV-2 and modulate harmful inflammation. Our findings ' 'highlight the potential therapeutic value of andrographolide in treating COVID-19, warranting ' 'further exploration in clinical trials. </jats:p>', 'DOI': '10.1177/1934578x241288428', 'type': 'journal-article', 'created': {'date-parts': [[2024, 10, 8]], 'date-time': '2024-10-08T10:29:59Z', 'timestamp': 1728383399000}, 'update-policy': 'http://dx.doi.org/10.1177/sage-journals-update-policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Effects and Mechanisms of Andrographolide for COVID-19: A Network Pharmacology-Based and ' 'Experimentally Validated Study', 'prefix': '10.1177', 'volume': '19', 'author': [ { 'given': 'Jingyi', 'family': 'Zhang', 'sequence': 'first', 'affiliation': [ { 'name': 'Department of Pathogenic Organism Biology, Henan University of ' 'Chinese Medicine, Zhengzhou, China'}, { 'name': 'School of Basic Medicine, Guangdong Medical University, ' 'Dongguan, China'}]}, { 'given': 'Hongmei', 'family': 'Lu', 'sequence': 'additional', 'affiliation': [ { 'name': 'The Second Clinical Medical School, Guangdong Medical ' 'University, Dongguan, China'}, { 'name': 'The First Dongguan Affiliated Hospital, Guangdong Medical ' 'University, Dongguan, China'}]}, { 'given': 'Yongdui', 'family': 'Ruan', 'sequence': 'additional', 'affiliation': [ { 'name': 'The First Dongguan Affiliated Hospital, Guangdong Medical ' 'University, Dongguan, China'}]}, { 'given': 'Shiyi', 'family': 'Huang', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Medical Technology, Guangdong Medical University, ' 'Dongguan, China'}]}, { 'given': 'Siying', 'family': 'Deng', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Pharmacy, Guangdong Medical University, Dongguan, ' 'China'}]}, { 'given': 'Yinuo', 'family': 'Wang', 'sequence': 'additional', 'affiliation': [{'name': 'Zhengzhou Foreign Language School, Zhengzhou, China'}]}, { 'given': 'Qing', 'family': 'Li', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Pathogenic Organism Biology, Henan University of ' 'Chinese Medicine, Zhengzhou, China'}]}, { 'given': 'Zuguo', 'family': 'Zhao', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Basic Medicine, Guangdong Medical University, ' 'Dongguan, China'}]}, { 'given': 'Long', 'family': 'Feng', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Pathogenic Organism Biology, Henan University of ' 'Chinese Medicine, Zhengzhou, China'}]}, { 'ORCID': 'http://orcid.org/0000-0002-6194-5687', 'authenticated-orcid': False, 'given': 'Wentao', 'family': 'Guo', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Basic Medicine, Guangdong Medical University, ' 'Dongguan, China'}, { 'name': 'The Second Clinical Medical School, Guangdong Medical ' 'University, Dongguan, China'}]}], 'member': '179', 'published-online': {'date-parts': [[2024, 10, 7]]}, 'reference': [ { 'key': 'bibr1-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S0140-6736(20)30183-5'}, { 'key': 'bibr2-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2001017'}, { 'key': 'bibr3-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41577-020-0311-8'}, { 'key': 'bibr4-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.pharmthera.2021.107843'}, { 'key': 'bibr5-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/life11040348'}, { 'key': 'bibr6-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/ph14111102'}, { 'key': 'bibr7-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1021/acs.jnatprod.0c01324'}, { 'key': 'bibr8-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/nar/gky1033'}, { 'key': 'bibr9-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/1758-2946-6-13'}, { 'key': 'bibr10-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/nar/gkx1037'}, { 'key': 'bibr11-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/nar/gkv1277'}, { 'key': 'bibr12-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/bioinformatics/btt540'}, { 'key': 'bibr13-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/nar/gkx1076'}, { 'key': 'bibr14-1934578X241288428', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/database/baq020', 'volume': '2010', 'author': 'Safran M', 'year': '2010', 'journal-title': 'Database: J Biol Databases Curat'}, { 'issue': '1', 'key': 'bibr15-1934578X241288428', 'volume': '48', 'author': 'Piñero J', 'year': '2020', 'journal-title': 'Nucleic Acids Res.'}, { 'key': 'bibr16-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/clpt.2012.96'}, { 'key': 'bibr17-1934578X241288428', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/nar/gky1131', 'volume': '47', 'author': 'Szklarczyk D', 'year': '2019', 'journal-title': 'Nucleic Acids Res.'}, { 'key': 'bibr18-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/s13059-019-1758-4'}, {'key': 'bibr19-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/75556'}, { 'key': 'bibr20-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/nar/28.1.235'}, { 'key': 'bibr21-1934578X241288428', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/nar/gkr366', 'volume': '39', 'author': 'Grosdidier A', 'year': '2011', 'journal-title': 'Nucleic Acids Res.'}, { 'key': 'bibr22-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jcc.21334'}, { 'key': 'bibr23-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/pro.3781'}, { 'key': 'bibr24-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/srep42717'}, { 'key': 'bibr25-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/22221751.2020.1743767'}, { 'key': 'bibr26-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.2174/0929867327666200810135604'}, { 'key': 'bibr27-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41598-021-89257-6'}, { 'key': 'bibr28-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/molecules26082210'}, { 'key': 'bibr29-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.21037/atm-20-7830'}, { 'key': 'bibr30-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41419-019-2195-8'}, { 'key': 'bibr31-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1021/jm070295s'}, { 'key': 'bibr32-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1177/13596535241259952'}, { 'key': 'bibr33-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S0140-6736(20)30628-0'}, { 'issue': '1', 'key': 'bibr34-1934578X241288428', 'first-page': '2', 'volume': '10', 'author': 'Chowdhury KH', 'year': '2021', 'journal-title': 'Biology (Basel).'}, { 'key': 'bibr35-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41392-020-0191-1'}, { 'key': 'bibr36-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/978-3-030-59261-5_11'}, { 'key': 'bibr37-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/ijms23031716'}, { 'key': 'bibr38-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s00134-020-05991-x'}, { 'key': 'bibr39-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/s12964-021-00770-7'}, { 'key': 'bibr40-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fbioe.2023.1110765'}, { 'key': 'bibr41-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41392-021-00791-1'}, { 'key': 'bibr42-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41467-023-40235-8'}, { 'key': 'bibr43-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.intimp.2022.109428'}, { 'key': 'bibr44-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/pathogens10050565'}, { 'key': 'bibr45-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fimmu.2022.990794'}, { 'key': 'bibr46-1934578X241288428', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/cells10061550'}], 'container-title': 'Natural Product Communications', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://journals.sagepub.com/doi/pdf/10.1177/1934578X241288428', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://journals.sagepub.com/doi/full-xml/10.1177/1934578X241288428', 'content-type': 'application/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://journals.sagepub.com/doi/pdf/10.1177/1934578X241288428', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 10, 8]], 'date-time': '2024-10-08T10:30:10Z', 'timestamp': 1728383410000}, 'score': 1, 'resource': {'primary': {'URL': 'https://journals.sagepub.com/doi/10.1177/1934578X241288428'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 10]]}, 'references-count': 46, 'journal-issue': {'issue': '10', 'published-print': {'date-parts': [[2024, 10]]}}, 'alternative-id': ['10.1177/1934578X241288428'], 'URL': 'http://dx.doi.org/10.1177/1934578X241288428', 'relation': {}, 'ISSN': ['1934-578X', '1555-9475'], 'subject': [], 'container-title-short': 'Natural Product Communications', 'published': {'date-parts': [[2024, 10]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit